Pipeline

ANNA has a focus on anti-cancer, anti-biotic and immunostimulating drugcandidates.

ANNA is currently doing research on a number of natural compounds, in combination of nanocarriers.

The current lead candidate is a nanocoated drugcandidate against multidrug resistant strains of MRSA and Klebsiella.